EGIPTNCT07211386
The Erector Spinae Plane Block For Gastrointestinal Malignancy Pain Treatment (EGIPT)
StatusTerminated
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Trial terminated Sponsor's reason: PI changed institutions Show 6 more changesShow less
- Final enrollment: 2 participants, 8% of the 25 planned
- Eligibility criteria expanded, about 9 words
- Primary completion date changed from estimate of May 15, 2027 to Apr 3, 2026
- Secondary endpoints: details revised at 1 of 3 entries
- Site details revised at 4 of 4 sites
- Publications: details revised at 2 of 2 entries
- Notable Start date: Oct 15, 2025 to Dec 11, 2025
- Site contacts updated at 1 of 4 sites
- Notable Lead sponsor: University of Pennsylvania to Abramson Cancer Center at Penn Medicinev2
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Opioid Consumption
Timeframe: 24 hours
Secondary (3)
Length of Stay
Pain Levels
Revised American Pain Society Patient Outcome Questionnaire
Arms and interventions
Treatment Arm -- Erector Spinae Plane BlockExperimental
Patients with gastrointestinal malignancy and abdominal pain will receive the erector spinae plane block for their abdominal pain.
Procedures: Erector Spinae Plane Block
Sites
4 sites in 1 country